These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Distinguishing dilemmas in the ethics of placebo-controlled trials. Kovach K Am J Bioeth; 2002; 2(2):32-3. PubMed ID: 12189072 [No Abstract] [Full Text] [Related]
23. Suicide risk in placebo-controlled trials of bipolar disorder. Goldney RD Am J Psychiatry; 2006 Feb; 163(2):329; author reply 329. PubMed ID: 16449498 [No Abstract] [Full Text] [Related]
24. Psychiatry. Are placebo-controlled drug trials ethical? Enserink M Science; 2000 Apr; 288(5465):416. PubMed ID: 10798970 [No Abstract] [Full Text] [Related]
25. Placebo orthodoxy in clinical research. I: Empirical and methodological myths. Freedman B; Weijer C; Glass KC J Law Med Ethics; 1996; 24(3):243-51. PubMed ID: 9069851 [No Abstract] [Full Text] [Related]
26. Consensus-seeking roundtable on placebos in clinical research. Weijer C NCEHR Commun; 1998-1999 Fall; 9(1):6-9. PubMed ID: 15468464 [No Abstract] [Full Text] [Related]
27. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Tenser RB; Polman CH Neurology; 2009 Mar; 72(13):1191-2; author reply 1192. PubMed ID: 19332703 [No Abstract] [Full Text] [Related]
28. Risk, Helsinki 2000 and the use of placebo in medical research. Saunders J; Wainwright P Clin Med (Lond); 2003; 3(5):435-9. PubMed ID: 14601942 [TBL] [Abstract][Full Text] [Related]
29. The placebo problem remains. Michels KB Arch Gen Psychiatry; 2000 Apr; 57(4):321-2. PubMed ID: 10768689 [No Abstract] [Full Text] [Related]
30. The ethics of AIDS vaccine trials. Macpherson CC Science; 1998 May; 280(5368):1330; author reply 1330-1. PubMed ID: 9634406 [No Abstract] [Full Text] [Related]
31. When do the federal regulations allow placebo-controlled trials in children? Miller FG; Wendler D; Wilfond B J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527 [No Abstract] [Full Text] [Related]
34. Declaration of Helsinki revised. Reynolds T J Natl Cancer Inst; 2000 Nov; 92(22):1801-3. PubMed ID: 11078756 [No Abstract] [Full Text] [Related]
35. Clinical trials: specific problems associated with the use of a placebo-control group. Cleophas TJ J Mol Med (Berl); 1995 Aug; 73(8):421-4. PubMed ID: 8528745 [TBL] [Abstract][Full Text] [Related]
36. The cult of the double-blind placebo-controlled trial. Ellis SJ; Adams RF Br J Clin Pract; 1997; 51(1):36-9. PubMed ID: 9158270 [TBL] [Abstract][Full Text] [Related]
37. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Temple R; Ellenberg SS Ann Intern Med; 2000 Sep; 133(6):455-63. PubMed ID: 10975964 [TBL] [Abstract][Full Text] [Related]
38. The powerful placebo: doubting the doubters. Greene PJ; Wayne PM; Kerr CE; Weiger WA; Jacobson E; Goldman P; Kaptchuk TJ Adv Mind Body Med; 2001; 17(4):298-307; discussion 312-8. PubMed ID: 11931055 [No Abstract] [Full Text] [Related]
39. Is there place for placebo controlled trials in the treatment of affective disorders? Fineberg NA; Gale TM; Hawley CJ Braz J Psychiatry; 2006 Jun; 28(2):89-90. PubMed ID: 16810388 [No Abstract] [Full Text] [Related]
40. Placebo controls in clinical trials of new therapies for osteoporosis. Levine RJ J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]